A cohort study of digoxin exposure and mortality in men with prostate cancer
Author:
Affiliation:
1. Department of Pharmacology and Therapeutics; Trinity College; University of Dublin; Dublin Ireland
2. National Cancer Registry Ireland; Cork Ireland
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12287/fullpdf
Reference57 articles.
1. Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth;Zhang;Proc Natl Acad Sci USA,2008
2. Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study;Vergis;Lancet Oncol,2008
3. Over-expression of hypoxia-inducible factor 1 alpha increases angiogenesis of LNCaP cells;Han;Zhonghua Nan Ke Xue,2007
4. Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer;Nanni;J Clin Invest,2009
5. Digoxin inhibits blood vessel density and HIF-1a expression in castration-resistant C4-2 xenograft prostate tumors;Gayed;Clin Transl Sci,2012
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sensational site: the sodium pump ouabain-binding site and its ligands;American Journal of Physiology-Cell Physiology;2024-04-01
2. Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library;Frontiers in Oncology;2022-08-18
3. Digoxin exerts anticancer activity on human nonsmall cell lung cancer cells by blocking PI3K/Akt pathway;Bioscience Reports;2021-10
4. Digoxin reduces the incidence of prostate cancer but increases the cancer‐specific mortality: A systematic review and pooled analysis;Andrologia;2021-08-19
5. Association Between Digoxin Use and Cancer Incidence: A Propensity Score-Matched Cohort Study With Competing Risk Analysis;Frontiers in Pharmacology;2021-03-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3